Type 2 diabetes mellitus, brain atrophy, and cognitive decline

• Published in: Neurology Vol. 92; no. 8; p. e823
• Main Authors: Moran, Chris, Beare, Richard, Wang, Wei, Callisaya, Michele, Srikanth, Velandai
• Format: Journal Article
• Language: English
• Published: United States 19.02.2019
• Subjects: Aged; Aged, 80 and over; Alzheimer Disease - diagnostic imaging; Alzheimer Disease - epidemiology; Atrophy - epidemiology; Blood Glucose - metabolism; Brain - diagnostic imaging; Brain - pathology; Cerebral Cortex - diagnostic imaging; Cerebral Cortex - pathology; Cognitive Dysfunction - diagnostic imaging; Cognitive Dysfunction - epidemiology; Diabetes Mellitus, Type 2 - epidemiology; Diabetes Mellitus, Type 2 - metabolism; Factor Analysis, Statistical; Female; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Organ Size
• ISSN: 1526-632X
• DOI: 10.1212/WNL.0000000000006955

To study longitudinal relationships between type 2 diabetes mellitus (T2DM), cortical thickness, and cognitive function in older people with normal cognition, mild cognitive impairment, and Alzheimer disease (AD). The sample was derived from the Alzheimer's Disease Neuroimaging Initiative cohort who underwent brain MRI and cognitive tests annually for 5 years. Presence of T2DM was based on fasting blood glucose ≥7.0mml/L or the use of glucose-lowering agents. We used latent growth curve modeling to explore longitudinal relationships between T2DM, cortical thickness, and cognitive function, adjusting for relevant covariates and testing for interactions. There were 124 people with T2DM (mean age 75.5 years, SD 6.2) and 693 without T2DM (mean age 75.1 years, SD 6.9) with at least 1 MRI available. AD and lower cortical thickness at study entry was associated with a lower chance of having a MRI available at each follow-up phase (all < 0.001). T2DM was associated with lower baseline cortical thickness ( = 0.01). We found no direct effect of T2DM on decline in cortical thickness or cognitive function, but there was an indirect pathway linking T2DM and cognitive decline via baseline cortical thickness (β = -0.17, = 0.022). There was an interaction between T2DM and education whereby the negative effect of T2DM on baseline cortical thickness was reduced in those with greater education (β = 0.34, = 0.037). These associations changed minimally when adjusted for baseline cognitive diagnosis. In an older cohort with low cerebrovascular disease burden, T2DM contributes to cognitive decline via neurodegeneration. Prior brain and cognitive reserve may protect against this effect.